T1	Treatment 11 29	MMX(®) mesalamine
T2	Treatment 115 130	with mesalamine
T3	Treatment 403 468	MMX(®) mesalamine (Lialda; Shire Pharmaceuticals LLC, Wayne, PA)
T4	Treatment 550 575	once-daily MMX mesalamine
T5	Treatment 590 671	twice-daily delayed-release mesalamine (Asacol; Warner Chilcott, Dublin, Ireland)
T6	Treatment 853 881	of once-daily MMX mesalamine
T7	Treatment 901 979	with twice-daily delayed-release mesalamine at a total daily dose of 1.6 g/day
